QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT07450378 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07450378
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-04-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.